… combined biomarkers and their usefulness in clinical practice for the early and preclinical
diagnosis … research on the accurate prediction, by combined biomarkers, of which people with …

… several biomarkers for plasma that is related to Alzheimer’s disease (AD). These biomarkers
include Aβ-… It is concluded that the use of combined plasma biomarkers not only allows the …

… There is a need for developing bloodborne biomarkers that can aid in the clinical diagnosis
… , biomarker-enriched approach that is more cost-effective than the current diagnosis of …

… for AD may potentially be complementary in diagnosis and prognosis of AD. Our aim was
to combine MR imaging, FDG-PET, and CSF biomarkers in the diagnostic classification and 2-…

… to diagnose it in its preclinical phase. The combination of cerebrospinal fluid (CSF) biomarkers
… It can provide an increased diagnostic accuracy. This review discusses the contribution of …

… -scale use of biomarkers. To elucidate the impact of age on biomarker diagnostic performance,
we … These results suggest that the relative extra information from combining biomarkers …

… Using multivariate Cox proportional hazards models to determine the best combination of
biomarkers for prognosis, we show here that a panel of markers consisting of calbindin, Aβ42, …

… Alzheimer's disease (AD). The present study was to investigate whether a combination of
plasma biomarkers and … reached the sensitivity and specificity required for AD biomarkers. The …

… identified in this cross-sectional analysis of data from the AIBL study may contribute toward
the development of a blood-based diagnostic test, which together with appropriate imaging …

… combined use is useful for diagnosing and monitoring the progress of AD. Therefore, further
development of a combination of these biomarkers … staging the Alzheimer disease spectrum …